[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346161-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346161-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","premature-mortality-and-years-of-potential-productive-life-lost-due-to-hpv-attributable-cancers-in-brazil-and-mexico-2011-versus-2023","Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023","","Human papillomavirus (HPV) remains a preventable cause of cancer mortality in Latin America. Mortality data from 2011 and 2023 for Brazil and Mexico were used to estimate HPV-attributable cancer deaths, years of life lost (YLL), average YLL, and years of potential productive life lost (YPPLL) by sex, age, and cancer type using attributable fractions. WHO life tables supported sensitivity analyses. HPV-attributable deaths rose from 6,515 to 9,533 in Brazil and from 4,303 to 4,997 in Mexico, with cervical cancer dominating. In 2023, YPPLL totaled 97,404 years in Brazil and 51,735 in Mexico, exceeding 2011 values; results highlight persistent preventable premature mortality and productivity loss.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/premature-mortality-and-years-of-potential-productive-life-lost-due-to-hpv-attributable-cancers-in-brazil-and-mexico-2011-versus-2023/346161/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/premature-mortality-and-years-of-potential-productive-life-lost-due-to-hpv-attributable-cancers-in-brazil-and-mexico-2011-versus-2023/346161.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What outcomes does the study estimate for HPV-attributable cancers in Brazil and Mexico?","Question",{"text":63,"@type":64},"It estimates HPV-attributable cancer deaths, years of life lost (YLL), average YLL, and years of potential productive life lost (YPPLL), stratified by sex, age, and cancer type using attributable fractions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do HPV-attributable deaths in 2023 compare with 2011 in Brazil and Mexico?",{"text":68,"@type":64},"HPV-attributable deaths were higher in 2023 than in 2011, rising in Brazil from 6,515 to 9,533 (YLL +44.6%) and in Mexico from 4,303 to 4,997 (YLL +21.4%).",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer type contributes the largest burden in both countries?",{"text":72,"@type":64},"Cervical cancer dominates the burden in both Brazil and Mexico. The introduction and abstract also note substantial HPV-attributable burden among men, including anal, penile, and head and neck cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346161,1790121458,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","RESEARCH ARTICLE     \nPremature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023  \nPaula Cristina Pungartnik a, Cintia Irene Parelladaa, Daniela Mayumi Usuda Prado Rochab, Rodrigo Gonçalves Queijob, Ana Luiza Bierrenbachb, and Juan Carlos Orengoc  \naOutcomes Research Latin America, MSD Brazil, São Paulo, Brazil; bPrecision Data, São Paulo, Brazil; cOutcomes Research Latin America, MSD (IA) LLC, Guaynabo, Puerto Rico  \nABSTRACT  \nHuman papillomavirus (HPV) remains a preventable cause of cancer mortality in Latin America. Using 2011 and 2023 mortality data from Brazil and Mexico, we estimated HPVattributable cancer deaths, years of life lost (YLL), average YLL, and years of potential productive life lost (YPPLL) by sex, age, and cancer type, applying attributable fractions. WHO life tables were used in sensitivity analyses. HPV‑attributable deaths were higher in 2023 than in 2011, increasing from 6,515 to 9,533 in Brazil (YLL +44.6%) and from 4,303 to 4,997 in Mexico (YLL +21 .4%) . These absolute differences were consistent with demographic change, while age-standardized mortality rates changed more modestly. Cervical cancer dominated the burden in both countries. Among men, oropharyngeal YLL was 33.5% and 74.6% higher in Brazil and Mexico in 2023 relative to 2011; the corresponding differences for penile cancer were 54.8% and 37.7%, respectively. Anal cancer YLL showed the largest relative differences in Brazil (+159.1% in women; +203.8% in men), whereas Mexico showed a smaller difference (+32.8% in men) . Although deaths were concentrated at ≥60y, substantial YLL and YPPLL occurred at younger age groups. In 2023, YPPLL totaled 97,404 y in Brazil and 51,735 y in Mexico, 43.9% and 26.7% higher than in 2011, respectively. WHO‑based sensitivity analyses yielded higher absolute YLL estimates but preserved relative patterns. These findings reveal a persistent and preventable burden of premature mortality and YPPLL from HPV‑attributable cancers in Brazil and Mexico, underscoring the need for expanded HPV vaccination, screening, timely diagnosis, and equitable treatment across affected cancer sites.  \nARTICLE HISTORY  \nReceived 20 April 2026 Revised 16 August 2026 Accepted 31 August 2026  \nKEYWORDS  \nHuman papillomavirus; cervical cancer; years of life lost; years of potential productive life lost; Latin America; mortality  \nIntroduction  \nHuman papillomavirus (HPV) is responsible for virtually all cervical cancers and a substantial proportion of other anogenital and head and neck cancers in both sexes. 1 In 2022, an estimated 422,935 deaths worldwide were attributable to HPV, representing 4 .5% of all cancer deaths.2 This burden is not evenly distributed: the majority of HPV-attributable deaths occur in low-and middle-income countries, reflecting persistent gapsin access to screening, vaccination, and timely treatment.3,4  \nThese inequities are particularly evident in Latin America and the Caribbean, where HPV-attributable cancers accounted for 62,809 deaths in 2022, representing approximately 8% of all cancer deaths and placing the region among those with the highest global burden.2,3,5,6 While cervical cancer contributes the largest share of mortality, HPV-attributable deaths among men, primarily from anal, penile, and head and neck cancers, are substantial and remain under-recognized in the region.2,7,8 Importantly, mortality counts alone underestimate the broader societal burden of HPV‑attributable cancers.  \nSummary measures such as years of life lost (YLL), average YLL (AYLL), and years of potential productive life lost (YPPLL) provide a more comprehensive assessment of disease burden by capturing premature mortality, the average lifespan reduction per death, and the loss of potential productive years due to deaths occurring during working ages.9 , 10 In high-income settings, these indicators have revealed a substantial burden. In 2017, HPV-attributabl","cbCaij3gLDeCWsvf","https://ap.wps.com/l/cbCaij3gLDeCWsvf","pdf",2962179,15,"English","# Abstract\n## Background\n## Burden and inequities in Latin America\n## Summary measures: YLL and YPPLL\n## Study context and significance","[{\"question\":\"What outcomes does the study estimate for HPV-attributable cancers in Brazil and Mexico?\",\"answer\":\"It estimates HPV-attributable cancer deaths, years of life lost (YLL), average YLL, and years of potential productive life lost (YPPLL), stratified by sex, age, and cancer type using attributable fractions.\"},{\"question\":\"How do HPV-attributable deaths in 2023 compare with 2011 in Brazil and Mexico?\",\"answer\":\"HPV-attributable deaths were higher in 2023 than in 2011, rising in Brazil from 6,515 to 9,533 (YLL +44.6%) and in Mexico from 4,303 to 4,997 (YLL +21.4%).\"},{\"question\":\"Which cancer type contributes the largest burden in both countries?\",\"answer\":\"Cervical cancer dominates the burden in both Brazil and Mexico. The introduction and abstract also note substantial HPV-attributable burden among men, including anal, penile, and head and neck cancers.\"}]","Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023 | PDF",1790060330,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67d712860ee7b6f4a712614ef27f23ee.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6077ba0b65cfb738c405ee200e34f864.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/482770d9993609790304a0321738abc5.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c120db394876a7712b9ab1d4428f60ed.webp",980,1306]